Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020

SELL
$14.22 - $18.38 $205,208 - $265,241
-14,431 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$12.22 - $17.99 $2,285 - $3,364
187 Added 1.31%
14,431 $210,000
Q4 2019

Feb 10, 2020

SELL
$14.63 - $17.84 $10,928 - $13,326
-747 Reduced 4.98%
14,244 $248,000
Q3 2019

Nov 04, 2019

BUY
$15.09 - $17.09 $633 - $717
42 Added 0.28%
14,991 $226,000
Q2 2019

Aug 13, 2019

BUY
$15.54 - $17.47 $232,307 - $261,159
14,949 New
14,949 $252,000
Q1 2019

May 02, 2019

SELL
$15.5 - $17.9 $312,077 - $360,398
-20,134 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$13.99 - $20.35 $82,331 - $119,759
5,885 Added 41.3%
20,134 $313,000
Q3 2018

Nov 07, 2018

BUY
$18.89 - $20.49 $269,163 - $291,962
14,249 New
14,249 $290,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Strategic Wealth Advisors Group, LLC Portfolio

Follow Strategic Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Advisors Group, LLC with notifications on news.